IPSC - Century Therapeutics, Inc.

Insider activity in IPSC over the last quarter tilts toward selling: insiders offloaded a net 5,033 shares worth roughly $10K.

Classified under Biotechnology (Health Care sector), IPSC's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Pfeiffenberger Brent	3.63M	$7.05M	-
Other	Cowan Chad	1.18M	$2.63M	-
Other	Russotti Gregory	509.2K	$982.8K	-
VP	Carr Douglas	502.9K	$970.6K	-

Buys and sells only

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 12, 2026	Russotti Gregory80	See Remarks	Sell	10,076	$2.55	$25,683.72	-1.9%	-15.2%	-
Mar 12, 2026	Carr Douglas54	SVP Finance &Operations	Sell	7,043	$2.55	$17,952.61	-1.4%	-15.2%	-
Mar 9, 2026	Carr Douglas54	SVP Finance &Operations	Sell	247	$2.54	$626.39	-	-27.9%	-
Mar 9, 2026	Russotti Gregory80	See Remarks	Sell	479	$2.54	$1,214.74	-	-27.9%	-
Feb 3, 2026	Carr Douglas54	SVP Finance &Operations	Sell	323	$1.82	$588.51	-	+24.5%	-
Dec 22, 2025	Cowan Chad	Chief Scientific Officer	Buy	58,060	$0.85	$49,252.30	+5.9%	+175.9%	-
Dec 12, 2025	Pfeiffenberger Brent	President and CEO	Buy	52,000	$0.58	$30,352.40	+1.6%	+348.3%	-
Dec 8, 2025	Russotti Gregory80	See Remarks	Sell	526	$0.53	$279.83	-0.1%	+415.8%	-
Dec 8, 2025	Carr Douglas54	SVP Finance &Operations	Sell	257	$0.53	$136.72	-	+415.8%	-
Nov 20, 2025	Cowan Chad	Chief Scientific Officer	Sell	5,462	$0.50	$2,736.46	-0.6%	+328.0%	-